image
Healthcare - Biotechnology - NASDAQ - US
$ 0.3901
-8.42 %
$ 26.1 M
Market Cap
-0.19
P/E
BALANCE SHEET
231 M ASSETS
-38.31%
145 M LIABILITIES
-15.52%
86.2 M EQUITY
-57.56%
BALANCE SHEET DECOMPOSITION
Balance Sheet Generation Bio Co.
image
Current Assets 193 M
Cash & Short-Term Investments 185 M
Receivables 0
Other Current Assets 7.68 M
Non-Current Assets 38.3 M
Long-Term Investments 0
PP&E 35.6 M
Other Non-Current Assets 2.69 M
80.11 %3.32 %15.40 %Total Assets$231.2m
Current Liabilities 35.1 M
Accounts Payable 1.41 M
Short-Term Debt 13 M
Other Current Liabilities 20.6 M
Non-Current Liabilities 110 M
Long-Term Debt 0
Other Non-Current Liabilities 110 M
8.97 %14.24 %75.82 %Total Liabilities$145.0m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
ASSETS
Cash & Cash Equivalents 76.3 66.4 93.2 375.1 62.9 15.1 7.3
Short Term Investments 108.9 197.9 185.9 0 199.4 0 67.6
Receivables 0 4.0 0.4 0 0 0.4 1.3
Inventory 0 1 0 0 0 1 0
Other Current Assets 2.6 4.3 7.5 7.4 10.8 2.6 0.8
Total Current Assets 192.9 272.6 287.0 379.2 267.7 18.2 76.9
PP&E 35.6 95.7 81.4 91.0 23.8 21.8 4.5
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 0 0 5.7 5.7 2.1 2.1 2.1
Other Long Term Assets 2.7 6.5 2.1 0.9 0.6 87 K 0
Other Assets 0 0 0 0 0 0 0
Total Assets 231.2 374.8 376.3 476.8 294.2 42.1 83.5
LIABILITIES
Accounts Payable 1.4 2.3 0.7 2.0 0.3 2.3 1.7
Short Term Debt 13.0 18.4 14.2 9.2 0 0 0
Other Current Liabilities 10.1 16.5 4.3 7.6 11.0 6.9 4.9
Total Current Liabilities 35.1 39.9 19.1 18.8 11.2 9.2 6.6
Long Term Debt 0 89.8 74.6 76.2 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0
Other Liabilities 109.9 0 0 0 0 115.6 115.6
Total Liabilities 145.0 171.6 93.8 95.0 26.1 140.7 125.1
EQUITY
Common Stock 7 K 7 K 6 K 6 K 5 K 1 K 1 K
Retained Earnings (703.0) (571.4) (444.8) (308.1) (189.0) (108.5) (47.1)
Other Accumulative Comprehensive Income/Loss 0.2 0.3 83 K 0 9 K (115.6) 9 K
Total Equity 86.2 203.1 282.5 381.7 268.0 (98.6) (41.6)
Total Liabilities and Equity 231.2 374.8 376.3 476.8 294.2 42.1 83.5
SHARES OUTSTANDING
Common Shares Outstanding 66.6 64.5 58.1 56.3 27.3 46.2 19.7